Clinical Trial Update: A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase I/II trial of an induction chemotherapy regimen consisting of daunorubicin, cytarabine, topotecan, and etoposide…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Daunorubicin (daunorubicin)
• Etoposide (Etoposide)
• Topotecan (topotecan)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Leukemia | Phase 1, Phase 2 | Status: COMPLETED